Solid Biosciences’ (SLDB) Market Outperform Rating Reaffirmed at JMP Securities
JMP Securities restated their market outperform rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a report released on Friday,Benzinga reports. They currently have a $15.00 price objective on the stock. SLDB has been the subject of a number of other reports. Barclays decreased their price objective on Solid Biosciences from $15.00 to […]
JMP Securities restated their market outperform rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a report released on Friday,Benzinga reports. They currently have a $15.00 price objective on the stock. SLDB has been the subject of a number of other reports. Barclays decreased their price objective on Solid Biosciences from $15.00 to […]
